BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 18508996)

  • 1. Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors.
    Halfdanarson TR; Rubin J; Farnell MB; Grant CS; Petersen GM
    Endocr Relat Cancer; 2008 Jun; 15(2):409-27. PubMed ID: 18508996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical management of pancreatic endocrine tumors.
    Fendrich V; Waldmann J; Bartsch DK; Langer P
    Nat Rev Clin Oncol; 2009 Jul; 6(7):419-28. PubMed ID: 19506584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Management of duodenal-pancreatic endocrine tumors].
    Partensky C
    J Chir (Paris); 2000 Jun; 137(3):142-50. PubMed ID: 10915980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferative rate in endoscopic ultrasound fine-needle aspiration of pancreatic endocrine tumors: correlation with clinical behavior.
    Alexiev BA; Darwin PE; Goloubeva O; Ioffe OB
    Cancer; 2009 Feb; 117(1):40-5. PubMed ID: 19347828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplantation for primary or secondary endocrine tumors.
    Gregoire E; Le Treut YP
    Transpl Int; 2010 Jul; 23(7):704-11. PubMed ID: 20492617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase activity in pancreatic endocrine tumors.
    Tang SJ; Dumot JA; Wang L; Memmesheimer C; Conwell DL; Zuccaro G; Goormastic M; Ormsby AH; Cowell J
    Am J Gastroenterol; 2002 Apr; 97(4):1022-30. PubMed ID: 12003383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups.
    Hochwald SN; Zee S; Conlon KC; Colleoni R; Louie O; Brennan MF; Klimstra DS
    J Clin Oncol; 2002 Jun; 20(11):2633-42. PubMed ID: 12039924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ductulo-insular pancreatic endocrine neoplasms: clinicopathologic analysis of a unique subtype of pancreatic endocrine neoplasms.
    Deshpande V; Selig MK; Nielsen GP; Fernandez-del Castillo C; Lauwers GY
    Am J Surg Pathol; 2003 Apr; 27(4):461-8. PubMed ID: 12657930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of pancreatic-duodenal endocrine tumors].
    O'Toole D; Kianmanesh R; Farges O; Ruszniewski P
    Rev Prat; 2002 Sep; 52(14):1546-53. PubMed ID: 12412302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical treatment of pancreatic endocrine neoplasms.
    Gomez-Rivera F; Stewart AE; Arnoletti JP; Vickers S; Bland KI; Heslin MJ
    Am J Surg; 2007 Apr; 193(4):460-5. PubMed ID: 17368289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endocrine tumors of the pancreas: classification, clinical and molecular prognostic factors].
    Terris B
    Ann Pathol; 2002 Oct; 22(5):367-74. PubMed ID: 12483154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of endocrine pancreatic tumors.
    Fjällskog ML; Janson ET
    Acta Oncol; 2005; 44(4):329-38. PubMed ID: 16120541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical treatment of gastrointestinal neuroendocrine tumors.
    Fendrich V; Bartsch DK
    Langenbecks Arch Surg; 2011 Mar; 396(3):299-311. PubMed ID: 21279821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival from malignant digestive endocrine tumors in England and Wales: a population-based study.
    Lepage C; Rachet B; Coleman MP
    Gastroenterology; 2007 Mar; 132(3):899-904. PubMed ID: 17383419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical therapy for endocrine tumors of abdominal origin.
    Sloan DA; Schwartz RW; Kenady DE
    Curr Opin Oncol; 1993 Jan; 5(1):100-9. PubMed ID: 8427883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Natural history and prognosis of pancreatic endocrine tumors].
    Ruszniewski P; Terris B
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Suppl):S20-5. PubMed ID: 12704289
    [No Abstract]   [Full Text] [Related]  

  • 17. An immunohistochemical study of cyclooxygenase (COX)-2 expression in endocrine tumors of the pancreas.
    Okami J; Nakamori S; Yamamoto H; Sakon M; Tsujie M; Hayashi N; Nagano H; Dono K; Umeshita K; Ishikawa O; Ohigashi H; Monden M
    J Exp Clin Cancer Res; 2002 Dec; 21(4):569-76. PubMed ID: 12636104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1.
    Kouvaraki MA; Shapiro SE; Cote GJ; Lee JE; Yao JC; Waguespack SG; Gagel RF; Evans DB; Perrier ND
    World J Surg; 2006 May; 30(5):643-53. PubMed ID: 16680581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life.
    Gonçalves TD; Toledo RA; Sekiya T; Matuguma SE; Maluf Filho F; Rocha MS; Siqueira SA; Glezer A; Bronstein MD; Pereira MA; Jureidini R; Bacchella T; Machado MC; Toledo SP; Lourenço DM
    J Clin Endocrinol Metab; 2014 Jan; 99(1):E89-96. PubMed ID: 24178797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PGP 9.5 immunocytochemical staining for pancreatic endocrine tumors.
    Tomita T
    Islets; 2013; 5(3):122-8. PubMed ID: 23959334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.